Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Oesophagogastric Cancer × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 66 Carcinoma, Hepatocellular 59 Stomach Neoplasms 48 Pancreatic Neoplasms 36 Rectal Neoplasms 27 Colonic Neoplasms 26 Neoplasms 19 Esophageal Neoplasms 18 Neoplasm Metastasis 15 Liver Neoplasms 15 Cholangiocarcinoma 14 Biliary Tract Neoplasms 12 Gallbladder Neoplasms 10 Esophageal Squamous Cell Carcinoma 10 Lung Neoplasms 7 Gastrointestinal Neoplasms 7 Adenocarcinoma Of Esophagus 7 Bile Duct Neoplasms 5 Adenocarcinoma 5 Prostatic Neoplasms 4 Polyps 4 Ovarian Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Adenoma 4 Recurrence 3 Peritoneal Neoplasms 3 Neoplasms by Site 3 Hematologic Neoplasms 3 Gastrointestinal Diseases 3 Digestive System Neoplasms 3

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡